Barclays sets USD 152 target for Procter & Gamble stock

Published on 10/19/2026 at 09:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Barclays set a USD 152.00 target on October 16, 2026. Procter & Gamble stock costs EUR 141.34 on October 19, 2026, below the EUR 141.62 Xetra close.

Target and fiscal performance

Barclays assigned a USD 152.00 target on October 16, 2026.
Fiscal 2026 net sales reached USD 87.0 billion, up 3 percent.
Procter & Gamble stock trades at EUR 141.34 at 9:05 a.m. CEST at Lang & Schwarz on October 19, 2026, 0.20 percent below the Xetra close of October 16, 2026.

Heller Supermarktgang mit Regalen voll ungebrandeter Haushalts- und Pflegeprodukte in Pastelltönen — Procter und Gamble US7427181091 zeigt breite Supermarkt Regale mit generischen Pflegeprodukten in hellen Pastellfarben, Illustration mit AI erstellt.

Procter & Gamble (ISIN US7427181091) stock costs EUR 141.34 at Lang & Schwarz on October 19, 2026 at 9:05 a.m. CEST, down 0.20 percent versus the Xetra close of October 16, 2026 at EUR 141.62. Barclays assigned a Hold rating and a USD 152.00 price target on October 16, 2026, according to Markets Insider.

Analyst targets set the tone

Recent coverage has produced a clear range of views. On October 6, 2026, Evercore ISI upgraded Procter & Gamble to Outperform from In Line and raised its target from USD 161.00 to USD 166.00, CNBC reported.

On the same date, Royal Bank of Canada kept an Outperform rating but lowered its target from USD 167.00 to USD 166.00, according to MarketBeat. Barclays therefore sits below the USD 172.00 target maintained by UBS on October 16, 2026, as reported by Investing.com.

What matters before October 22?

Procter & Gamble is scheduled to report first-quarter fiscal 2027 results before the market opens on October 22, 2026. UBS expects adjusted earnings per share of USD 1.85 against a Visible Alpha consensus of USD 1.89, while the company targets fiscal 2027 core earnings per share of USD 6.89 to USD 7.11, according to Investing.com.

The operating backdrop combines modest growth with cost sensitivity. Procter & Gamble's fiscal 2026 net sales reached USD 87.0 billion, up 3 percent, while organic sales growth and core earnings per share growth were each 1 percent, according to Procter & Gamble. Operating cash flow was USD 19.6 billion in fiscal 2026, giving the upcoming report a cash-generation metric alongside the sales and earnings figures.

Stock remains near its yearly high

The euro quotation is close to its 52-week high of EUR 142.42 and well above the 52-week low of EUR 118.22, based on the October 16, 2026 quote. Market capitalization stood at EUR 328.9 billion on that date, while the primary listing is on the NYSE in USD.

The next concrete dates are the first-quarter fiscal 2027 results on October 22, 2026 and the USD 1.0885 dividend payment on November 16, 2026. UBS expects management to address the effect of commodity costs and the pace of organic sales growth in the new fiscal year.

Price and investor perspective

Barclays' USD 152.00 target places its valuation reference above the current euro quotation, but the coming report will determine whether sales momentum supports the fiscal 2027 outlook. Procter & Gamble stock was trading at EUR 141.34 at Lang & Schwarz on October 19, 2026 at 9:05 a.m. CEST, 0.20 percent below the Xetra close of October 16, 2026 at EUR 141.62. The further course of trading is shown by the continuously updated real-time quote of Procter & Gamble stock.